Novo Nordisk Aktie
80,14
EUR
-19,41
EUR
-19,50
%
79,20
EUR
-20,10
EUR
-20,24
%
Novo Nordisk Aktie Analyse
| 04.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 04.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 01.11.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 30.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 27.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 24.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Reduce | HSBC | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk Halten | Independent Research GmbH | |
| 20.09.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 30.08.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.08.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.08.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 12.08.19 | Novo Nordisk Reduce | HSBC | |
| 09.08.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |